Nabriva Therapeutics Plc (NBRV)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

56 FITZWILLIAM SQUARE DUBLIN, IRELAND 2

Nabriva Therapeutics AG operates as a clinical stage biopharmaceutical company. The Company focuses on the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. Nabriva Therapeutics serves communities and hospitals worldwide.

Data based on most recent fiscal year report
Market Cap166.206 Million Shares Outstanding36.69 Million Avg Volume420.161 Thousand
1-Yr BETA vs S&P TR1.105 Current Ratio7.08 Quick Ratio7.08
View SEC Filings from NBRV instead.
Q4 2018 All Institutions Hedge Funds 1
To trade NBRV now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 48 13 (1.29%)
Aggregate 13F shares on 12/31/2018: 32.212 Million 13.94 Million
Aggregate 13F shares on 09/30/2018: 31.871 Million 14.182 Million
Percent change: 1.07% -1.70%
Funds creating new positions: 13 3
Funds Adding to an existing position: 7 2
Funds closing out their position: 9 1
Funds reducing their position: 16 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NBRV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KHUONG CHAU QUANG

  • Director
1,471,725 2019-03-07 0

BOURDOW CARRIE L. PRESIDENT AND CEO

  • Officer
  • Director
304,500 2019-02-01 1

GELONE STEVEN P. PRESIDENT & COO

  • Officer
0 2019-01-31 4

SENDER GARY CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-31 2

CROTTY ROBERT GEN COUNSEL & CORP SECRETARY

  • Officer
0 2019-01-31 2

LAVINO FRANCESCO MARIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-01-31 2

SCHRANZ JENNIFER CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-31 3

SCHROEDER THEODORE R CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-01-31 3

WEBSTER STEPHEN W CHIEF FINANCIAL OFFICER

  • Officer
6,102 2019-01-18 2

ROWLAND CHARLES A JR

  • Director
0 2019-01-02 3

CORRIGAN MARK

  • Director
0 2018-08-09 1

BURGESS DANIEL D

  • Director
36,000 2018-07-31 2

TALBOT GEORGE HARRISON

  • Director
47,640 2018-07-31 2

BROOM COLIN MD CEO & DIRECTOR

  • Officer
  • Director
175,000 2018-06-22 2

BOLTE AXEL

  • Director
0 2018-06-08 0

VIVO CAPITAL VIII, LLC

  • 10% Owner
16,128,515 2018-03-07 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ISALY SAMUEL D

  • Director
941,000 2017-12-08 0

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
No longer subject to file 2017-09-12 0

SELTZER ELYSE G. CHIEF MEDICAL OFFICER

  • Officer
2,400 2017-06-23 0

WOLF JOHN PETER III GENERAL COUNSEL AND CORP. SEC.

  • Officer
270 2016-12-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GELONE STEVEN P. - Officer PRESIDENT & COO

2019-01-31 A 278,400 a 278,400 0.00 direct

SCHROEDER THEODORE R - Director - Officer CHIEF EXECUTIVE OFFICER

2019-01-31 A 163,250 a 163,250 0.00 direct

SCHRANZ JENNIFER - Officer CHIEF MEDICAL OFFICER

2019-01-31 A 235,000 a 235,000 0.00 direct

LAVINO FRANCESCO MARIA - Officer CHIEF COMMERCIAL OFFICER

2019-01-31 A 52,500 a 52,500 0.00 direct

SENDER GARY - Officer CHIEF FINANCIAL OFFICER

2019-01-31 A 138,200 a 138,200 0.00 direct

SCHROEDER THEODORE R - Director - Officer CHIEF EXECUTIVE OFFICER

2019-01-31 A 429,800 a 429,800 0.00 direct

CROTTY ROBERT - Officer GEN COUNSEL & CORP SECRETARY

2019-01-31 A 52,500 a 52,500 0.00 direct

LAVINO FRANCESCO MARIA - Officer CHIEF COMMERCIAL OFFICER

2019-01-31 A 138,200 a 138,200 0.00 direct

GELONE STEVEN P. - Officer PRESIDENT & COO

2019-01-31 A 105,750 a 105,750 0.00 direct

SCHRANZ JENNIFER - Officer CHIEF MEDICAL OFFICER

2019-01-31 A 52,500 a 52,500 0.00 direct

CROTTY ROBERT - Officer GEN COUNSEL & CORP SECRETARY

2019-01-31 A 138,200 a 138,200 0.00 direct

SENDER GARY - Officer CHIEF FINANCIAL OFFICER

2019-01-31 A 52,500 a 52,500 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments